The primer is meant to push back on a specific claim made after @cochranecollab was out: FULL CLAIM: Review “failed to find even a ‘modest effect’ on infection or illness rate”; “the CDC Grossly Exaggerated the Evidence Supporting Mask Mandates”. 2/
As @HealthFeedback says: "Claims that face masks are ineffective at reducing the spread of COVID-19 based on a Cochrane review didn’t take into account the limitations of the review." 3/
"While many users presented this review as the highest-quality evidence, the individual studies it evaluated varied greatly in terms of quality, study design, populations studied, and outcomes observed, which prevented the authors from drawing any definitive conclusions." 4/
.@HealthFeedback continues: "Randomized controlled trials are considered the gold standard when assessing the effectiveness of an intervention." 5/
"However, this type of study can vary greatly in quality, particularly in complex interventions such as face masks, affecting the reliability of the results." 6/
"In this context, many scientists consider that randomized controlled trials should be seen as a part of broader evidence including other study designs." 7/
"When taking those studies into account, evidence suggests that widespread mask usage can reduce community transmission of SARS-CoV-2, especially when combined with other interventions like frequent handwashing and physical distancing." end/
• • •
Missing some Tweet in this thread? You can try to
force a refresh
I wish Bret Stephens would stop opining on things he clearly doesn’t understand. @JenniferNuzzo and @Jabaluck have talked about what the Cochrane review on masks tells and doesn’t tell us from a scientific perspective. Read their 🧵s. 1/
This is a problem. While there are any number of good science reporters at the @nytimes, opinion writers like Stephens and @DLeonhardt consistently get things wrong and there is never a correction in sight. 2/
This does two things: undermines real science reporting as an “look at me, anyone can do it” sport and misinforms readers of the paper. 3/
My comrade Paul Farmer died a year ago. Today, @PesteMagazine is publishing a series of reflections on Paul’s life and legacy by his friends and colleagues. 1/ pestemag.com/featured-posts…
One other question for Joe Kahn: you feel the desperate need to showcase views that challenge the rights of women to bodily autonomy, criticize “woke-ism”, ask for religious tolerance for public discrimination against gay people, as promoting “both sides” of the issues. 1/
But I do seriously want to know, where the threshold is for the @nytimes. Where would a view be so abhorrent that you might even admit that both-sides-ing is impossible? 2/
And I am not challenging the right of anyone to say terrible things in the public square. But when and where does it become bad for business to offer page space to certain views? Or does it never? 3/
We’ve heard from @_Eric_Reinhart this week on the grinding down of American healthcare workers by a system, hell-bent on extracting profit above all else in America. 1/ nytimes.com/2023/02/05/opi…
So, reporters don't write the headlines, but why does the phrase "big government" never get scrutinized as if "less is more" (always) in terms of federal spending unmoored from discussions about the values the underlie our choices. 1/ nytimes.com/2023/02/08/us/…
I'm not criticizing @jimtankersley but just curious about why what is frankly a pejorative term (i.e. big government) gets bandied about so much without any context. It's as if limited government in and of itself is some platonic ideal. 2/
In fact, we are told by the @nytimes that political reporting is, well, apolitical: "Our reputation for independence rests upon the public’s faith that we can carry out our work free from influence and overt bias." 3/ nytimes.com/article/new-yo…